SLXNW · Silexion Therapeutics Corp · Short Interest
$0.00
+0.00 (+0.00%)
At close · Nov 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of September 30, 2026, we had cash and cash equivalents of $4.8 million. Based on our current cash balance, as well as our history of operating losses and negative cash flows from operations, combined with our anticipated use of cash to, among other things, (i) fund the clinical development of SIL204, (ii) identify and develop new product candidates, and (iii) seek approval for SIL204 and any other product candidates we may develop, our management has concluded that we do not have sufficient cash to fund our operations for 12 months from the issuance date of our consolidated financial statements for the three-month and nine-month periods ended September 30, 2026 included in this quarterly report, but rather, for only several months from the filing date of this quarterly report, under our current business plan, as a result, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 12, 2026
Market Cap
$974,292
Shares
649,528
Volume · Nov 19
300
Avg daily vol (3M)
39.06K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
SLXNW Latest Reported Short Interest
FINRA reported 63,197 SLXNW shares sold short as of the October 30, 2026 settlement date, a decrease of 19,493 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent splits of this listing
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-11-30
Scheduled
FINRA publishes Dec 9
|
— | — | — | — |
|
2026-11-13
Scheduled
FINRA publishes Nov 24
|
— | — | — | — |
| 2026-10-30 | 63,197 | 82,690 | -19,493 | 1.00 |
| 2026-10-15 | 82,690 | 81,317 | +1,373 | 5.65 |
| 2026-09-30 | 81,317 | 79,465 | +1,852 | 5.63 |
| 2026-09-15 | 79,465 | 80,250 | -785 | 20.69 |
| 2026-08-31 | 80,250 | 74,765 | +5,485 | 11.14 |
| 2026-08-14 | 74,765 | 80,845 | -6,080 | 8.73 |
| 2026-07-31 | 80,845 | 5,732 | +75,113 | 1.00 |
| 2026-07-15 | 5,732 | 5,748 | -16 | 14.97 |
| 2026-06-30 | 5,748 | 5,522 | +226 | 1.00 |
| 2026-06-15 | 5,522 | 5,522 | 0 | 1.00 |
| 2026-05-29 | 5,522 | 5,522 | 0 | 1.00 |
| 2026-05-15 | 5,522 | 6,384 | -862 | 1.00 |
| 2026-04-30 | 6,384 | 5,981 | +403 | 1.18 |
| 2026-04-15 | 5,981 | 5,522 | +459 | 1.65 |
| 2026-03-31 | 5,522 | 6,922 | -1,400 | 1.00 |
| 2026-03-13 | 6,922 | 7,722 | -800 | 1.12 |
| 2026-02-27 | 7,722 | 7,722 | 0 | 4.66 |
| 2026-02-13 | 7,722 | 7,722 | 0 | 1.00 |
| 2026-01-30 | 7,722 | 7,722 | 0 | 1.00 |
| 2026-01-15 | 7,722 | 15,051 | -7,329 | 1.00 |
| 2025-12-31 | 15,051 | 11,629 | +3,422 | 1.00 |
| 2025-12-15 | 11,629 | 10,097 | +1,532 | 1.00 |
| 2025-11-28 | 10,097 | 9,555 | +542 | 1.50 |
Full FINRA short interest reporting calendar
Showing 1–23 of 23 settlements
Key facts
CIK
2022416
CUSIP
G1281K148
13F (30d)
27 filings
21 filers
Visit website
Investor relations